Skip to main content
Clinical Trials/NCT05142852
NCT05142852
Completed
Not Applicable

Analgesic Effect of Extracorporeal Shock Wave Therapy in Individuals With Lateral Epicondylitis: A Randomized Controlled Trial

Salameh Aldaja1 site in 1 country43 target enrollmentJune 5, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lateral Epicondylitis
Sponsor
Salameh Aldaja
Enrollment
43
Locations
1
Primary Endpoint
Visual Analog Scale
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

A sample of 40 patients poststroke (24 males) was randomly allocated to either ESWT experimental (n=18) or conventional physiotherapy control group (n=20). All patients received 5 sessions during the treatment program. The Visual Analog Scale (VAS) and Taiwan version Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire, and dynamometer (Maximal grip strength) for each participant were assessed before and after the treatment program.

Detailed Description

The participants in the experiment group received 5 consecutive sessions of ESWT for 5 minutes. Treatment parameters for the shock wave therapy group were set similar to a previous study (Devrimsel et al., 2013) 2000 shock waves with 1.6 bar intensity and 16 Hz frequency were applied for five sessions using the Swiss DolorClast Master (EMS, Nyon, Switzerland). The participants in the control group received 5 sessions of conventional physical therapy intervention for 5 minutes. The control group intervention consists of a 1-minute friction massage over the common extensor tendon of the elbow, followed by 3 minutes therapeutic ultrasound with a frequency of 1.5 Hz, and a 1-minute ice massage over the common extensor tendon of the elbow. All participants used 10-cm lateral epicondyle bandages in the treatment period, while none of them received analgesic or anti-inflammatory drugs and received exercise programs.

Registry
clinicaltrials.gov
Start Date
June 5, 2021
End Date
September 4, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Salameh Aldaja
Responsible Party
Sponsor Investigator
Principal Investigator

Salameh Aldaja

Associate Professor

Isra University, Jordan

Eligibility Criteria

Inclusion Criteria

  • An inclusion criterion was a confirmed diagnosis of lateral epicondylitis with lateral elbow pain lasting more than 6 months and less than 1 year.

Exclusion Criteria

  • Participants were excluded from this study if they had cervical radiculopathy, elbow deformity, history of diabetes mellitus, hypo- or hyperthyroidism, history of malignancy, chronic inflammatory diseases, and pregnancy. Patients who received corticosteroid injections to the lateral epicondyle within 6 weeks were also excluded.

Outcomes

Primary Outcomes

Visual Analog Scale

Time Frame: Change from baseline Visual Analog Scale at 5 day

Participants were asked to rate their present pain intensity, as caused by the lateral epicondylitis, from zero to 10 using the Visual Analog Scale (VAS).

Secondary Outcomes

  • Upper extremity disability and symptoms(Change from baseline Upper extremity disability and symptoms at 5 day)
  • Maximal grip strength(Change from baseline maximal grip strength at 5 day)

Study Sites (1)

Loading locations...

Similar Trials